Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-30

FDA Approved: CASPOFUNGIN ACETATE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved caspofungin acetate for the treatment of invasive candidiasis (including candidemia) and esophageal candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caspofungin Acetate (caspofungin acetate)

Snippet

ORIG AP for CASPOFUNGIN ACETATE (CASPOFUNGIN ACETATE)